Thyago Proenca de Moraes
Overview
Explore the profile of Thyago Proenca de Moraes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almeida N, Pellizzari C, Leinig C, Nerbass F, Moraes T
J Bras Nefrol
. 2025 Mar;
47(2):e20230205.
PMID: 40080790
Introduction: Interdialytic weight gain (IDWG) is a risk factor for cardiovascular complications and mortality in hemodialysis (HD) patients. Sodium and fluid intake are important modifiable risk factors for these outcomes,...
2.
Azevedo L, Banin V, Dias D, Mendes M, Alves C, Silva M, et al.
Einstein (Sao Paulo)
. 2024 Dec;
22:eAO0980.
PMID: 39661863
Objective: The efficacy of icodextrin versus glucose patients undergoing peritoneal dialysis remains unclear. The study was designed to compare the effects of once-daily long-dwell icodextrin versus glucose on markers of...
3.
Rico-Fontalvo J, Reina M, Soler M, Unigarro-Palacios M, Castaneda-Gonzalez J, Quintero J, et al.
J Bras Nefrol
. 2024 Nov;
46(4):e20240101.
PMID: 39514688
GLP1 receptor agonists (GLP1-RAs) are drugs that mimic the effects of the incretin hormone GLP1 and were initially introduced in medicine for the treatment of diabetes in 2005 and for...
4.
Machado Junior P, Lass A, Pilger B, Fornazari R, Moraes T, Pinho R
J Bras Nefrol
. 2024 Oct;
46(4):e20230187.
PMID: 39412512
Diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease (CKD) worldwide. The pathogenesis of DKD is influenced by functional, histopathological, and immune mechanisms, including NLRP3 inflammasome activity...
5.
Moraes T, Pellizzari C
J Bras Nefrol
. 2024 Sep;
46(3):e2024E008.
PMID: 39241117
No abstract available.
6.
Dariva M, Guedes M, Rigodon V, Kotanko P, Larkin J, Ferlin B, et al.
Perit Dial Int
. 2024 Apr;
45(1):44-51.
PMID: 38596899
Background: Hypertension is a leading cause of kidney failure, affects most dialysis patients and associates with adverse outcomes. Hypertension can be difficult to control with dialysis modalities having differential effects...
7.
8.
Tuma I, Cambi M, Moraes T, Magro D, Kotze P
Arq Gastroenterol
. 2024 Mar;
61:e23088.
PMID: 38451660
Background: Inflammatory bowel diseases (IBD) are associated with important changes in nutritional status. Objective: The aim of the study was to compare body fat composition between two anthropometric methods: skinfolds...
9.
Parolin S, Stocco R, Kneipp Lopes J, Curcio Pereira M, Massae Yamashita M, Domareski Goulart M, et al.
Diabetol Metab Syndr
. 2023 Sep;
15(1):185.
PMID: 37697407
Background: This study aimed to determine the association between glycemic variability (GV) and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods: We prospectively analyzed data from inpatients (> ...
10.
Franco R, Chula D, Moraes T, Campos R
Front Nephrol
. 2023 Sep;
2:985449.
PMID: 37675012
In Brazil, most hemodialysis (HD) patients are treated by the country's public health system. However, accessibility to healthcare is different for public and private patients. This study aimed to identify...